Clintrial s.r.o.

The medical center is at the forefront of dermatology research, focusing on innovative treatments for skin conditions such as atopic dermatitis and plaque psoriasis. Through extensive clinical trials, the center evaluates the safety and efficacy of novel therapies, aiming to improve patient outcomes and quality of life.

• Atopic Dermatitis
• Plaque Psoriasis

By exploring new therapeutic agents and delivery methods, the center contributes significantly to the advancement of dermatological care.

Specializing in psychiatry, the medical center conducts pioneering research on mental health disorders, including schizophrenia and major depressive disorder (MDD). The focus is on developing adjunctive therapies that enhance the effectiveness of existing treatments, providing hope for patients with inadequate responses to standard care.

• Schizophrenia
• Major Depressive Disorder (MDD)

Through rigorous clinical trials, the center aims to uncover new insights into the pathophysiology of these conditions, paving the way for more personalized and effective treatment strategies.

The center is a leader in rheumatology research, particularly in the treatment of rheumatoid arthritis. By comparing biosimilars and reference products, the center seeks to provide cost-effective and accessible treatment options for patients suffering from this chronic inflammatory disorder.

• Rheumatoid Arthritis

Research efforts are directed towards understanding the immunogenicity and long-term safety of these therapies, ensuring that patients receive the most effective care possible.

In the field of neurology, the medical center is dedicated to advancing the treatment of Alzheimer's disease and cognitive impairments associated with schizophrenia. By evaluating new pharmacological interventions, the center aims to slow disease progression and improve cognitive function in affected individuals.

• Alzheimer's Disease
• Cognitive Impairment in Schizophrenia

The center's research contributes to a deeper understanding of neurodegenerative processes, offering hope for more effective management of these challenging conditions.